Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ionis Pharmaceuticals

30.71
+0.90003.02%
Pre-market: 31.500.7900+2.57%08:00 EDT
Volume:2.41M
Turnover:73.81M
Market Cap:4.88B
PE:-10.12
High:31.82
Open:31.78
Low:29.85
Close:29.81
Loading ...

Ionis Pharmaceuticals: on Track for Second Independent Launch With Donidalorsen Pdufa August 21, 2025

THOMSON REUTERS
·
Yesterday

Ionis reports first quarter 2025 financial results

Business Wire
·
Yesterday

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Yesterday

New Harris Poll findings reveal HAE patients are unsatisfied with current prophylactic treatment options, with over 90% interested in trying new therapies

Business Wire
·
29 Apr

Press Release: Ionis to hold first quarter 2025 financial results webcast

Dow Jones
·
16 Apr

Ionis Pharmaceuticals Price Target Maintained With a $60.00/Share by Needham

Dow Jones
·
15 Apr

Ionis Pharmaceuticals price target lowered to $52 from $55 at Morgan Stanley

TIPRANKS
·
11 Apr

Morgan Stanley Keeps Their Hold Rating on Ionis Pharmaceuticals (IONS)

TIPRANKS
·
11 Apr

Ionis Pharmaceuticals (IONS) Surges 8.9%: Is This an Indication of Further Gains?

Zacks
·
10 Apr

Ionis Pharmaceuticals Price Target Maintained With a $60.00/Share by Needham

Dow Jones
·
08 Apr

BUZZ-U.S. STOCKS ON THE MOVE-Janover, AMC Entertainment, U.S. Steel

Reuters
·
07 Apr

BUZZ-H.C. Wainwright initiates coverage for Ionis  Pharma with 'buy' rating citing pending drug launches

Reuters
·
07 Apr

HC Wainwright Initiates Ionis Pharmaceuticals With Buy Rating, $45 Price Target

MT Newswires Live
·
07 Apr

Ionis Pharmaceuticals Initiated at Buy by HC Wainwright & Co.

Dow Jones
·
07 Apr

Ionis Pharmaceuticals, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating and Target Price $45

THOMSON REUTERS
·
07 Apr

Ionis Pharmaceuticals management to meet with Oppenheimer

TIPRANKS
·
05 Apr

Ionis to host expert panel discussion on sHTG

Business Wire
·
03 Apr

Biogen's BIIB080 Gets FDA Fast-Track Designation in Alzheimer's Disease

Dow Jones
·
02 Apr

Ionis Pharmaceuticals Initiated at Neutral by Redburn Atlantic

Dow Jones
·
31 Mar

Redburn Atlantic Initiates Ionis Pharmaceuticals at Neutral With $39 Price Target

MT Newswires Live
·
31 Mar